PMID: 2505290Jan 1, 1989Paper

Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat

Psychopharmacology
I Q Whishaw, R N Auer

Abstract

In a series of experiments, rats received the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK-801 and measures were made of motor behavior, spatial navigation in a swimming pool, and electroencephalographic (EEG) activity. High doses (0.25-10 mg/kg IV) produced somnolence and akinesia, impaired food consumption, locomotion and swimming, and also impaired navigation to a hidden platform but complete recovery on all measures was obtained between 3 and 5 days postinjection. Lower doses (0.05-0.10 mg/kg, IV) impaired acquisition of a new place response in a swimming pool and produced hyperactivity but did not impair performance on a new cue response or on a well-learned place response. Two forms of hippocampal EEG activity, atropine-sensitive and atropine-resistant EEG were present with the low doses. The results demonstrate that a single dose of MK-801 causes changes in motor behavior and learning lasting a few days, but complete recovery occurs within 5 days of administration of even very high doses of MK-801. They further demonstrate that low doses of the drug selectively impair acquisition of new place responses. Although the general changes in behavior produced by MK-801 suggest that NMDA receptors are involved in man...Continue Reading

References

Feb 1, 1986·Annals of Neurology·S M Rothman, J W Olney
Aug 21, 1987·European Journal of Pharmacology·J W McDonaldM V Johnston
Sep 23, 1987·European Journal of Pharmacology·M D TricklebankS D Iversen
Feb 1, 1988·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·E OzyurtJ McCulloch
May 1, 1988·Pharmacology, Biochemistry, and Behavior·M J Benvenga, T C Spaulding
Jan 27, 1988·European Journal of Pharmacology·J Willetts, R L Balster
Sep 23, 1987·European Journal of Pharmacology·J OlneyG Frierdich
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E H WongL L Iversen
Aug 4, 1987·European Journal of Pharmacology·G E HandelmannT L O'Donohue
May 1, 1974·Journal of Comparative and Physiological Psychology·T E Robinson, I Q Whishaw
Jun 24, 1982·Nature·R G MorrisJ O'Keefe
Apr 1, 1964·International nursing review· VON GADOW

❮ Previous
Next ❯

Citations

Jun 1, 1994·Amino Acids·W Danysz, T Archer
Jan 1, 1992·Journal of Neural Transmission. General Section·S Behrens, W F Gattaz
Jan 1, 1997·Journal of Neural Transmission·J StecherS Hoyer
Jan 1, 1991·Psychopharmacology·R F Genovese, X C Lu
Jan 1, 1990·Psychopharmacology·D F WozniakJ P Miller
Jan 1, 1994·Journal of Neural Transmission. General Section·A FredrikssonT Archer
Feb 9, 1993·European Journal of Pharmacology·P H WuH Kalant
Sep 1, 1992·Physiology & Behavior·W S StoneP E Gold
Nov 24, 1995·Mechanisms of Ageing and Development·P Saransaari, S S Oja
Sep 1, 1990·Pharmacology, Biochemistry, and Behavior·R L McLambH A Tilson
Dec 1, 1990·Pharmacology, Biochemistry, and Behavior·D Corbett
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·K A Trujillo, H Akil
Jun 11, 1991·Pharmacology, Biochemistry, and Behavior·G J KantC P D'Angelo
Jun 1, 1991·Pharmacology, Biochemistry, and Behavior·P RobledoC L Ehlers
Oct 1, 1991·Pharmacology, Biochemistry, and Behavior·L RajachandranL P Spear
Mar 1, 1993·Pharmacology, Biochemistry, and Behavior·R Lalonde, C C Joyal
May 1, 1995·Pharmacology, Biochemistry, and Behavior·E L Hargreaves, D P Cain
Jun 1, 1995·Pharmacology, Biochemistry, and Behavior·P Filliat, G Blanchet
Mar 1, 1996·Pharmacology, Biochemistry, and Behavior·G Brosnan-WattersJ W Olney
Mar 1, 1993·Behavioral and Neural Biology·R J FishkinR W Dunn
Jan 1, 1993·Brain Research. Brain Research Reviews·R K McNamara, R W Skelton
Aug 1, 1994·Brain Research. Brain Research Reviews·C H Vanderwolf, D P Cain
Jun 30, 1994·Behavioural Brain Research·H Dai, R J Carey
Jul 1, 1995·Neuroscience Research·R E SteinpreisM C Piwowarczyk
Apr 1, 1995·Current Opinion in Neurobiology·T G Aigner
Aug 18, 2001·Pharmacology, Biochemistry, and Behavior·S B HarrodD C Riccio
Mar 25, 1998·Pharmacology, Biochemistry, and Behavior·A M White, P J Best
Feb 11, 1999·Pharmacology, Biochemistry, and Behavior·G Brosnan-WattersJ W Olney
Mar 18, 1999·Pharmacology, Biochemistry, and Behavior·B E Hetzler, H K Burkard
May 14, 1998·Neuroscience and Biobehavioral Reviews·I Q Whishaw

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved